Human beta-defensins (HBD1 and HBD3) and malignant melanoma susceptibility

Melanoma Res. 2009 Oct;19(5):340-1. doi: 10.1097/CMR.0b013e328330106a.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Case-Control Studies
  • Genotype
  • Humans
  • Melanoma / genetics*
  • Melanoma / metabolism
  • Polymorphism, Single Nucleotide
  • Skin Neoplasms / genetics*
  • Skin Neoplasms / metabolism
  • beta-Defensins / genetics*
  • beta-Defensins / metabolism

Substances

  • DEFB1 protein, human
  • DEFB103A protein, human
  • beta-Defensins